China Risun Group Ltd. (HK:1907)
:1907
Want to see HK:1907 full AI Analyst Report?
Top Page
China Risun Group Ltd.
(1907)
Select Model
Select Model
Rating:42Neutral
Price Target:
HK$2.50
▲(11.61% Upside)
Action:Reiterated
Date:05/02/26
The score is driven primarily by weakened financial performance (near-breakeven margins, declining revenue, and rising leverage), which outweighs the improvement in recent cash flow. Technicals are neutral-to-slightly constructive over the longer term but not strong enough to offset fundamentals. Valuation is the major additional drag due to the very high P/E versus thin earnings.
Positive Factors
Improved cash generation
A swing to positive free cash flow and a large OCF increase provide durable funding flexibility: the company can fund working capital and maintenance capex internally, reducing near-term reliance on external financing and enabling gradual deleveraging or targeted reinvestment if sustained.
Negative Factors
Profitability deterioration
Near-breakeven margins and declining revenue materially weaken the firm's ability to generate sustainable operating earnings. Thin operating profitability magnifies sensitivity to input costs and pricing cycles, limiting reinvestment, dividend capacity, and the ability to rebuild reserves over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved cash generation
A swing to positive free cash flow and a large OCF increase provide durable funding flexibility: the company can fund working capital and maintenance capex internally, reducing near-term reliance on external financing and enabling gradual deleveraging or targeted reinvestment if sustained.
Read all positive factors
China Risun Group Ltd. (1907) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$12.03B
Dividend Yield1.16%
Average Volume (3M)6.86M
Price to Earnings (P/E)156.2
Beta (1Y)0.36
Revenue Growth-17.38%
EPS Growth224.44%
CountryHK
Employees7,389
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)0.02
Shares Outstanding4,454,186,000
10 Day Avg. Volume6,618,426
30 Day Avg. Volume6,856,105
Financial Highlights & Ratios
PEG Ratio0.86
Price to Book (P/B)0.72
Price to Sales (P/S)0.23
P/FCF Ratio14.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.94Price Target Upside76.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.31
Revenue Forecast (FY)HK$46.37B
China Risun Group Ltd. Business Overview & Revenue Model
Company Description
China Risun Group Limited, together with its subsidiaries, produces, sells, and distributes coke, coking chemicals, and refined chemicals in the People's Republic of China. The company operates through four segments: Coke and Coking Chemicals Manu...
How the Company Makes Money
null...
China Risun Group Ltd. Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
38
Negative
Cash Flow
41
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 39.29B | 47.54B | 46.07B | 43.14B | 39.37B |
| Gross Profit | 3.06B | 3.49B | 3.32B | 4.28B | 5.53B |
| EBITDA | 3.09B | 3.50B | 4.37B | 4.63B | 5.45B |
| Net Income | 58.01M | 20.13M | 860.81M | 1.86B | 2.61B |
Balance Sheet | |||||
| Total Assets | 61.89B | 59.84B | 53.84B | 46.10B | 36.80B |
| Cash, Cash Equivalents and Short-Term Investments | 5.08B | 2.26B | 1.25B | 1.40B | 2.37B |
| Total Debt | 37.20B | 30.38B | 26.31B | 20.70B | 16.70B |
| Total Liabilities | 46.80B | 43.96B | 39.36B | 33.51B | 25.69B |
| Stockholders Equity | 12.50B | 12.76B | 12.90B | 12.11B | 10.98B |
Cash Flow | |||||
| Free Cash Flow | 622.44M | -1.24B | 134.87M | -1.22B | 534.69M |
| Operating Cash Flow | 3.46B | 1.44B | 2.20B | 3.16B | 4.21B |
| Investing Cash Flow | -3.41B | -3.64B | -1.71B | -9.18B | -5.13B |
| Financing Cash Flow | -570.24M | 3.05B | -455.15M | 4.93B | 2.02B |
China Risun Group Ltd. Technical Analysis
Negative
2.24
Price Trends
3.14
Negative
2.78
Negative
2.57
Positive
Market Momentum
-0.11
Positive
40.00
Neutral
48.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1907, the sentiment is Negative. The current price of 2.24 is below the 20-day moving average (MA) of 2.95, below the 50-day MA of 3.14, and below the 200-day MA of 2.57, indicating a neutral trend. The MACD of -0.11 indicates Positive momentum. The RSI at 40.00 is Neutral, neither overbought nor oversold. The STOCH value of 48.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1907.
China Risun Group Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$19.49B | 9.92 | 11.90% | 0.98% | 1.21% | 108.04% | |
69 Neutral | HK$3.79B | 7.87 | 6.29% | 6.70% | -4.96% | 15.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$1.12B | 18.35 | 2.57% | 3.52% | 1.20% | -7.22% | |
59 Neutral | HK$1.24B | 7.49 | 7.36% | 2.20% | -7.41% | 65.65% | |
55 Neutral | HK$5.56B | 7.86 | 7.70% | ― | -5.68% | -25.13% | |
42 Neutral | HK$12.03B | 156.16 | 0.46% | 1.16% | -17.38% | 224.44% |
* Basic Materials Sector Average
HK:1907
China Risun Group Ltd.
2.65
0.23
9.32%
HK:0609
Tiande Chemical Holdings Limited
1.26
0.18
16.67%
HK:1702
Dongguang Chemical Ltd.
1.99
0.33
19.88%
HK:0189
Dongyue Group Limited
11.83
2.96
33.37%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
4.53
2.76
155.93%
HK:0746
Lee & Man Chemical Co. Ltd.
4.46
1.14
34.22%
China Risun Group Ltd. Corporate Events
China Risun buys Binhai Energy stake in push into new energy battery materials
Apr 29, 2026
China Risun Group Limited has moved to deepen its presence in new energy battery materials by agreeing to acquire a 14.5% stake in Binhai Energy for RMB571.2 million from Xuyang Holding, a vehicle controlled by its chairman and controlling shareho...
China Risun Sets 2026 AGM to Approve 2025 Results, Dividend and Share Issue Mandate
Apr 28, 2026
China Risun Group Limited has called its annual general meeting for May 29, 2026, in Hong Kong, where shareholders will review the board report and audited financial statements for the year ended December 31, 2025. They will also vote on the re-el...
China Risun Updates Final Dividend Timetable and Payout Details
Apr 28, 2026
China Risun Group Limited has updated details of its final cash dividend for the financial year ended 31 December 2025, confirming a payout of RMB 0.0019 per share, equivalent to HKD 0.0022 based on an exchange rate of RMB 1 to HKD 1.141. Sharehol...
China Risun Lifts Profit on Higher Output Despite Revenue Decline in 2025
Mar 29, 2026
China Risun Group Limited reported higher output in 2025, with coke production rising 7.8% to 17.8 million tons and refined chemical processing up 5.0% to 5.2 million tons, while high-purified hydrogen volumes surged 25.7% to 25.3 million Nm3. Des...
China Risun Proposes Final Dividend for 2025 Financial Year
Mar 29, 2026
China Risun Group Limited has proposed a final ordinary cash dividend of RMB 0.0019 per share for the financial year ended 31 December 2025, subject to shareholder approval. The dividend, linked to the company’s audited annual results for 20...
China Risun Sets March 27 Board Meeting to Approve 2025 Results and Mull Dividend
Mar 17, 2026
China Risun Group Limited has scheduled a board meeting for March 27, 2026 to review and approve the annual results for the year ended December 31, 2025. The board will also consider the proposal of a final dividend, signaling a routine but import...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.